Switzerland· 65275008
Spedra 200 mg, Tabletten
A avanafil product containing avanafilum, registered in Switzerland by Curatis AG and dispensed under Swissmedic category B. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Avanafil is registered in 14 of 19 countries.
Countries holding a registration under ATC G04BE10 (avanafil), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Avanafil · ATC G04BE10
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of avanafil costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Avanafil · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- IT Italy$4.50
The record
At a glance
Swissmedic (Switzerland)- Active substance
- avanafilum
- Manufacturer
- Curatis AG
- Country
- Switzerland (CH)
- ATC code
- G04BE10
- ATC class
- Avanafil
- Defined daily dose
- 0.1 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for avanafil.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Avanafil · interactions on record
81 records
- 21 severe
- 60 moderate
Most severe, free to view
- AprepitantA04AD12severe
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Avanafil in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSPEDRAPhoenix Labs Unlimited Company, Clonee
- SpainSPEDRA 200 mg comprimidosPhoenix Labs Unlimited Company
- United KingdomSpedra 200mg tabletsA. Menarini Farmaceutica Internazionale SRL
- IrelandSpedra 200 mg tabletsPhoenix Labs Unlimited Company
- IcelandSpedraMenarini International Operations Luxembourg S.A.
- NetherlandsSpedra, tabletten van 200 mgPhoenix Labs Unlimited Company
- NorwaySpedraMenarini International Operations Luxembourg S.A.
- PolandSpedraMenarini International Operations Luxembourg S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Spedra
- Liechtenstein · Spedra
- Norway · Spedra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f59f9de5-3b0d-4920-9abc-d9a0a64c81bc GET /v1/drugs/f59f9de5-3b0d-4920-9abc-d9a0a64c81bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about avanafil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.